ArticlePloS one2012

Economic evaluation of first-line treatments for metastatic renal cell carcinoma: a cost-effectiveness analysis in a health resource-limited setting.

Bin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.